NCT00371293View on ClinicalTrials.gov

The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease

NACompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2013

Conditions
Sleep Apnea SyndromesInflammation
Interventions
BEHAVIORAL

Weight Loss Program

Participants in the weight loss program will receive weekly dietary counseling and will be encouraged to decrease caloric intake and increase physical activity.

DEVICE

CPAP therapy

Participants receiving CPAP therapy will use a CPAP machine each night while they sleep.

Trial Locations (2)

19014

Philadelphia Veterans Affairs Medical Center, Philadelphia

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pennsylvania

OTHER

NCT00371293 - The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease | Biotech Hunter | Biotech Hunter